Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares
(NQ:
KNSA
)
20.59
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
October 01, 2024
– Life DisRPted is an educational campaign aimed at promoting early diagnosis and treatment of recurrent pericarditis, a painful and debilitating chronic autoinflammatory disease –
From
Kiniksa Pharmaceuticals, Ltd.
Via
GlobeNewswire
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Via
AB Newswire
Topics
ETFs
Exposures
Product Safety
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
The biotech sector is finally beginning to recover following a two year stretch of underperformance that was largely driven by rising interest rates and other macro factors. Biotech has a track record...
Via
TheNewswire.com
Topics
ETFs
Exposures
Product Safety
Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) Near the Top of Equities by Percentage Gain on 7/25
July 25, 2023
Via
Investor Brand Network
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.